AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 75 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,269 | -16.7% | 16,903 | -33.2% | 0.00% | – |
| Q2 2023 | $23,136 | -70.1% | 25,285 | -81.7% | 0.00% | -100.0% |
| Q1 2023 | $77,356 | +60.0% | 138,037 | +64.8% | 0.00% | +100.0% |
| Q4 2022 | $48,334 | +504.2% | 83,768 | +220.5% | 0.00% | – |
| Q3 2022 | $8,000 | -38.5% | 26,134 | -26.6% | 0.00% | – |
| Q2 2022 | $13,000 | -43.5% | 35,599 | +10.7% | 0.00% | -100.0% |
| Q1 2022 | $23,000 | -68.9% | 32,169 | -2.3% | 0.00% | -66.7% |
| Q4 2021 | $74,000 | +19.4% | 32,911 | +54.1% | 0.00% | +50.0% |
| Q3 2021 | $62,000 | +29.2% | 21,361 | +52.1% | 0.00% | -33.3% |
| Q1 2021 | $48,000 | -75.3% | 14,046 | -54.2% | 0.00% | +200.0% |
| Q4 2019 | $194,000 | +240.4% | 30,694 | +198.4% | 0.00% | 0.0% |
| Q4 2018 | $57,000 | – | 10,285 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $13,027,000 | 5.13% |
| Orchard Capital Management, LLC | 857,138 | $2,400,000 | 1.02% |
| Nantahala Capital Management | 7,040,487 | $19,713,000 | 0.61% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 209,040 | $585,000 | 0.18% |
| Woodline Partners LP | 2,382,522 | $6,671,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,546,169 | $4,329,000 | 0.15% |
| Virtus ETF Advisers LLC | 92,771 | $260,000 | 0.11% |
| Jump Financial, LLC | 155,583 | $435,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 128,626 | $360,000 | 0.06% |
| Anson Funds Management LP | 95,342 | $267,000 | 0.05% |